SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-060222
Filing Date
2021-12-14
Accepted
2021-12-14 09:16:49
Documents
13
Period of Report
2021-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20211213.htm   iXBRL 8-K 37761
2 EX-99.1 drrx-ex991_6.htm EX-99.1 11709
  Complete submission text file 0001564590-21-060222.txt   179692

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20211213.xsd EX-101.SCH 5677
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20211213_lab.xml EX-101.LAB 18580
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20211213_pre.xml EX-101.PRE 11029
6 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20211213_htm.xml XML 3407
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 211489811
SIC: 2834 Pharmaceutical Preparations